Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dierlamm, J
Right arrow Articles by Cassiman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dierlamm, J
Right arrow Articles by Cassiman, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features [see comments]

J Dierlamm, S Pittaluga, I Wlodarska, M Stul, J Thomas, M Boogaerts, L Michaux, A Driessen, C Mecucci and JJ Cassiman

Department of Pathology, University of Leuven, Belgium.

Clinical, histologic, cytogenetic, and molecular genetic data of 31 patients with extranodal, nodal, and splenic marginal zone B-cell lymphoma (MZBCL) are presented. Despite these variable clinical manifestations, a similar spectrum of morphologic features as well as distinctive immunophenotypic findings were noted. In all cases, a monotypic B-cell proliferation consistently negative for CD5, CD10, and CD23 was found expanding the marginal zone of the B follicle with and without colonization of the follicle centers. Clonal chromosomal abnormalities were detected in 23 of the 31 patients. Recurrent aberrations included whole or partial trisomy 3 (18 cases), trisomy 18 (9 cases), and structural rearrangements of chromosome 1 with breakpoints in 1q21 (9 cases) or 1p34 (6 cases), all of which were seen in extranodal, nodal, as well as splenic MZBCL. Abnormalities of the additional chromosome 3, such as +del(3)(p13),+i(3)(q10), or structural changes involving the distal part of the long arm, were evident in 9 of the 18 cases. All recurrent abnormalities were found in MZBCL more frequently than in other histologic entities of B-cell non-Hodgkin's lymphoma (B-NHL). None of the known lymphoma-associated chromosomal changes or rearrangements of the BCL1, BCL2, BCL3, BCL6, and CMYC genes were detected. We conclude that MZBCL represent a distinct entity of B- NHL with characteristic morphologic and immunophenotypic features and particular chromosomal abnormalities, and that a close histogenetic relationship between extranodal, nodal, and splenic MZBCL is likely, although the clinical presentation may vary.

Volume 87, Issue 1, pp. 299-307, 01/01/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
haematolHome page
R. J. Bende, F. van Maldegem, and C. J.M. van Noesel
Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas
Haematologica, August 1, 2009; 94(8): 1109 - 1123.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Novak, A. Rinaldi, I. Kwee, S. V. Nandula, P. M. V. Rancoita, M. Compagno, M. Cerri, D. Rossi, V. V. Murty, E. Zucca, et al.
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Blood, May 14, 2009; 113(20): 4918 - 4921.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Braggio, J. J. Keats, X. Leleu, S. Van Wier, V. H. Jimenez-Zepeda, R. Valdez, R. F.J. Schop, T. Price-Troska, K. Henderson, A. Sacco, et al.
Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-{kappa}B Signaling Pathways in Waldenstrom's Macroglobulinemia
Cancer Res., April 15, 2009; 69(8): 3579 - 3588.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
B. Kahl and D. Yang
Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL
Hematology, January 1, 2008; 2008(1): 359 - 364.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Pfeifer, M. Pantic, I. Skatulla, J. Rawluk, C. Kreutz, U. M. Martens, P. Fisch, J. Timmer, and H. Veelken
Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays
Blood, February 1, 2007; 109(3): 1202 - 1210.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. Ghesquieres, F. Berger, P. Felman, E. Callet-Bauchu, P.-A. Bryon, A. Traverse-Glehen, C. Thieblemont, L. Baseggio, A.-S. Michallet, B. Coiffier, et al.
Clinicopathologic Characteristics and Outcome of Diffuse Large B-Cell Lymphomas Presenting With an Associated Low-Grade Component at Diagnosis
J. Clin. Oncol., November 20, 2006; 24(33): 5234 - 5241.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
V. E. Valli, W. Vernau, L.-P de Lorimier, P. S. Graham, and P. F. Moore
Canine Indolent Nodular Lymphoma
Vet. Pathol., May 1, 2006; 43(3): 241 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
G. Troen, V. Nygaard, T.-K. Jenssen, I. M. Ikonomou, A. Tierens, E. Matutes, A. Gruszka-Westwood, D. Catovsky, O. Myklebost, G. Lauritzsen, et al.
Constitutive Expression of the AP-1 Transcription Factors c-jun, junD, junB, and c-fos and the Marginal Zone B-Cell Transcription Factor Notch2 in Splenic Marginal Zone Lymphoma
J. Mol. Diagn., November 1, 2004; 6(4): 297 - 307.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Hosokawa, H. Suzuki, Y. Suzuki, R. Takahashi, and M. Seto
Antiapoptotic Function of Apoptosis Inhibitor 2-MALT1 Fusion Protein Involved in t(11;18)(q21;q21) Mucosa-Associated Lymphoid Tissue Lymphoma
Cancer Res., May 15, 2004; 64(10): 3452 - 3457.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Franco, A. M. Florena, and E. Iannitto
Splenic marginal zone lymphoma
Blood, April 1, 2003; 101(7): 2464 - 2472.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
X Mariette
Lymphomas complicating Sjogren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells
Ann Rheum Dis, November 1, 2001; 60(11): 1007 - 1011.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Conconi, F. Bertoni, E. Pedrinis, T. Motta, E. Roggero, S. Luminari, C. Capella, M. Bonato, F. Cavalli, and E. Zucca
Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes
Blood, August 1, 2001; 98(3): 781 - 786.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. M. Hernandez, J. L. Garcia, N. C. Gutierrez, M. Mollejo, J. A. Martinez-Climent, T. Flores, M. B. Gonzalez, M. A. Piris, and J. F. San Miguel
Novel Genomic Imbalances in B-Cell Splenic Marginal Zone Lymphomas Revealed by Comparative Genomic Hybridization and Cytogenetics
Am. J. Pathol., May 1, 2001; 158(5): 1843 - 1850.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
F. Cavalli, P. G. Isaacson, R. D. Gascoyne, and E. Zucca
MALT Lymphomas
Hematology, January 1, 2001; 2001(1): 241 - 258.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Dierlamm, M. Baens, M. Stefanova-Ouzounova, K. Hinz, I. Wlodarska, B. Maes, A. Steyls, A. Driessen, G. Verhoef, P. Gaulard, et al.
Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes
Blood, September 15, 2000; 96(6): 2215 - 2218.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. L. Pandolfino, R. S. Siegel, T. M. Kuzel, S. T. Rosen, and J. Guitart
Primary Cutaneous B-Cell Lymphoma: Review and Current Concepts
J. Clin. Oncol., May 10, 2000; 18(10): 2152 - 2168.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Baens, B. Maes, A. Steyls, K. Geboes, P. Marynen, and C. De Wolf-Peeters
The Product of the t(11;18), an API2-MLT Fusion, Marks Nearly Half of Gastric MALT Type Lymphomas without Large Cell Proliferation
Am. J. Pathol., April 1, 2000; 156(4): 1433 - 1439.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Berger, P. Felman, C. Thieblemont, T. Pradier, L. Baseggio, P.-A. Bryon, G. Salles, E. Callet-Bauchu, and B. Coiffier
Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients
Blood, March 15, 2000; 95(6): 1950 - 1956.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. B. Callanan, P. Le Baccon, P. Mossuz, S. Duley, C. Bastard, R. Hamoudi, M. J. Dyer, G. Klobeck, R. Rimokh, J. J. Sotto, et al.
The IgG Fc receptor, Fcgamma RIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma
PNAS, January 4, 2000; 97(1): 309 - 314.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Rosenwald, G. Ott, S. Stilgenbauer, J. Kalla, M. Bredt, T. Katzenberger, A. Greiner, M. M. Ott, B. Gawin, H. Dohner, et al.
Exclusive Detection of the t(11;18)(q21;q21) in Extranodal Marginal Zone B Cell Lymphomas (MZBL) of MALT Type in Contrast to other MZBL and Extranodal Large B Cell Lymphomas
Am. J. Pathol., December 1, 1999; 155(6): 1817 - 1821.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Dierlamm, M. Baens, I. Wlodarska, M. Stefanova-Ouzounova, J. M. Hernandez, D. K. Hossfeld, C. De Wolf-Peeters, A. Hagemeijer, H. Van den Berghe, and P. Marynen
The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene, MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas
Blood, June 1, 1999; 93(11): 3601 - 3609.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Ott, J. Kalla, A. Steinhoff, A. Rosenwald, T. Katzenberger, U. Roblick, M. M. Ott, and H. K. Muller-Hermelink
Trisomy 3 Is Not a Common Feature in Malignant Lymphomas of Mucosa-Associated Lymphoid Tissue Type
Am. J. Pathol., September 1, 1998; 153(3): 689 - 694.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. F.E. Barth, H. Dohner, C. A. Werner, S. Stilgenbauer, M. Schlotter, M. Pawlita, P. Lichter, P. Moller, and M. Bentz
Characteristic Pattern of Chromosomal Gains and Losses in Primary Large B-Cell Lymphomas of the Gastrointestinal Tract
Blood, June 1, 1998; 91(11): 4321 - 4330.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Tierens, J. Delabie, S. Pittaluga, A. Driessen, and C. DeWolf-Peeters
Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B Lymphocyte Subsets
Blood, April 1, 1998; 91(7): 2381 - 2386.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T.G. Willis, I.R. Zalcberg, L.J.A. Coignet, I. Wlodarska, M. Stul, D.M. Jadayel, C. Bastard, J.G. Treleaven, D. Catovsky, M.L.M. Silva, et al.
Molecular Cloning of Translocation t(1;14)(q21;q32) Defines a Novel Gene (BCL9) at Chromosome 1q21
Blood, March 15, 1998; 91(6): 1873 - 1881.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Royer, D. Cazals-Hatem, J. Sibilia, F. Agbalika, J.-M. Cayuela, T. Soussi, F. Maloisel, J.-P. Clauvel, J.-C. Brouet, and X. Mariette
Lymphomas in Patients With Sjogren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses
Blood, July 15, 1997; 90(2): 766 - 775.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020